Europe Radiopharmaceuticals Market - Industry Trends and Forecast to 2030

Europe Radiopharmaceuticals Market - Industry Trends and Forecast to 2030


The Europe radiopharmaceuticals market is expected to reach USD 3,487.24 million by 2030 from USD 2,205.41 million in 2022, growing at a CAGR of 5.9% during the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation
Europe Radiopharmaceuticals Market, By Type (Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals), Application (Diagnostic and Therapeutic), Source (Nuclear reactors and Cyclotrons), End User (Hospitals, Diagnostic Centers, Cancer research institutes, Ambulatory surgical centers, and Others), Country (Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, and rest of Europe) - Industry Trends and Forecast to 2030
Overview of Europe Radiopharmaceuticals Market Dynamics


Driver
• Growing demand for radiopharmaceuticals in diagnostics and clinical use

Restraint

• Potential risks associated with radiopharmaceuticals

Opportunity

• Rising research and development expenditure of radiopharmaceuticals


Market Players

Some of the major market players operating in the Europe radiopharmaceuticals market are:

• Cardinal Health
• Advanced Accelerator Applications, A Novartis Company
• Lantheus
• Curium Inc
• GENERAL ELECTRIC COMPANY
• Jubliant Radiopharma, A Jubilant Pharma Company
• China lsotope & Radiation Corporation
• Bracco
• Eckert & Ziegler
• SHINE Technologies, LLC
• IBA Worldwide
• Institute of Isotopes
• Siemens Healthcare GmBH


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Europe Radiopharmaceuticals Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market Testing Type Coverage Grid
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’s Five Forces
4.3 Pipeline Analysis
4.4 Patent Analysis
4.5 Drug Treatment Rate By Matured Markets
4.6 Demographic Trends: Impacts On All Incidence Rates
4.7 Patient Flow Diagram
4.8 Key Pricing Strategies
4.9 Key Patient Enrollment Strategies
5 List Of Cyclotrons
5.1 Europe
6 Regulatory Scenario
6.1 Europe
7 Market Overview
7.1 Drivers
7.1.1 The Growing Demand For Radiopharmaceuticals In Diagnostics And Clinical Use
7.1.2 The Increasing Need For Pharmaceutical Products Across Varied Therapeutic Areas
7.1.3 The Increasing Prevalence Of Chronic Diseases
7.2 Restraints
7.2.1 Stringent Regulations For Radiopharmaceuticals
7.2.2 Potential Risks Associated With Radiopharmaceuticals
7.3 Opportunities
7.3.1 The Rising Research And Development Expenditure Of Radiopharmaceuticals
7.3.2 The Growing Incidences Of Complex Diseases In Geriatric Population
7.4 Challenges
7.4.1 High Cost Of Development And Implementation Of Radiopharmaceuticals
7.4.2 Lack Of Technical Expertise And High Cost For Training Existing Workforce
8 Europe Radiopharmaceuticals Market, By Type
8.1 Overview
8.2 Diagnostic Radiopharmaceuticals
8.2.1 Pet Radiopharmaceuticals
8.2.1.1 F-18
8.2.1.2 Ru-82
8.2.1.3 Other Pet Isotopes Radiopharmaceuticals
8.2.2 Spect Radiopharmaceuticals
8.2.2.1 Technetium-99m
8.2.2.2 Gallium-67
8.2.2.3 Iodine-123
8.2.2.4 Thallium-201
8.2.2.5 Other Spect Isotopes
8.3 Therapeutic Radiopharmaceuticals
8.3.1 Brachytherapy Isotopes
8.3.1.1 Iodine-125
8.3.1.2 Palladium-103
8.3.1.3 Cesium-131
8.3.1.4 Iridium-192
8.3.1.5 Other Brachytherapy Isotopes 91 
8.3.2 Beta Emitters
8.3.2.1 Iodine-131
8.3.2.2 Luthetium-177
8.3.2.3 Samarium-153
8.3.2.4 Yttrium-90
8.3.2.5 Rhenium-186
8.3.2.6 Other Beta Emitters
8.3.3 Alpha Emitters
8.3.3.1 Ra-223
8.3.3.2 Others
9 Europe Radiopharmaceuticals Market, By Application
9.1 Overview
9.2 Diagnostic
9.2.1 Pet
9.2.1.1 Oncology
9.2.1.2 Cardiology
9.2.1.3 Neurology
9.2.1.4 Other Pet Application
9.2.2 Spect
9.2.2.1 Cardiology
9.2.2.2 Bone Scans
9.2.2.3 Thyroid Applications
9.2.2.4 Pulmonary Scans
9.2.2.5 Other Spect Application
9.3 Therapeutic
9.3.1 Thyroid Indications
9.3.2 Bone Metastasis
9.3.3 Lymphoma
9.3.4 Endocrine Tumors
9.3.5 Other Indications
10 Europe Radiopharmaceuticals Market, By Source
10.1 Overview
10.2 Nuclear Reactors
10.3 Cyclotrons 107 
11 Europe Radiopharmaceuticals Market, By End User
11.1 Overview
11.2 Hospitals
11.3 Diagnostic Centers
11.4 Cancer Research Institutes
11.5 Ambulatory Surgical Centers
11.6 Others
12 Europe Radiopharmaceutical Market
12.1 Europe
12.1.1 Germany
12.1.2 U.K.
12.1.3 France
12.1.4 Italy
12.1.5 Spain
12.1.6 Belgium
12.1.7 Poland
12.1.8 Russia
12.1.9 Norway
12.1.10 Turkey
12.1.11 Austria
12.1.12 Ireland
12.1.13 Hungary
12.1.14 Netherlands
12.1.15 Switzerland
12.1.16 Rest Of Europe
13 Company Landscape
13.1 Company Share Analysis: Europe
14 Swot Analysis
15 Company Profile
15.1 Cardinal Health
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Development
15.2 Advanced Accelerator Applications, A Novartis Company
15.2.1 Company Snapshot
15.2.2 Revenue Analysis
15.2.3 Company Share Analysis
15.2.4 Product Portfolio
15.2.5 Recent Development
15.3 Lantheus
15.3.1 Company Snapshot
15.3.2 Revenue Analysis
15.3.3 Company Share Analysis
15.3.4 Product Portfolio
15.3.5 Recent Development
15.4 Curium
15.4.1 Company Snapshot
15.4.2 Company Share Analysis
15.4.3 Product Portfolio
15.4.4 Recent Development
15.5 General Electric Company
15.5.1 Company Snapshot
15.5.2 Revenue Analysis
15.5.3 Company Share Analysis
15.5.4 Product Portfolio
15.5.5 Recent Development
15.6 Bracco
15.6.1 Company Snapshot
15.6.2 Product Portfolio
15.6.3 Recent Development
15.7 China Isotope & Radiation Corporation
15.7.1 Company Snapshot
15.7.2 Revenue Analysis
15.7.3 Product Portfolio
15.7.4 Recent Development
15.8 Eckert & Ziegler
15.8.1 Company Snapshot
15.8.2 Revenue Analysis
15.8.3 Product Portfolio
15.8.4 Recent Development 247 
15.9 Iba Worldwide
15.9.1 Company Snapshot
15.9.2 Revenue Analysis
15.9.3 Product Portfolio
15.9.4 Recent Development
15.10 Institute Of Isotopes
15.10.1 Company Snapshot
15.10.2 Product Portfolio
15.10.3 Recent Development
15.11 Jubilant Radiopharma A Jubilant Pharmova Company
15.11.1 Company Snapshot
15.11.2 Revenue Analysis
15.11.3 Product Portfolio
15.11.4 Recent Development
15.12 Shine Technologies, Llc
15.12.1 Company Snapshot
15.12.2 Product Portfolio
15.12.3 Recent Development
15.13 Siemens Healthcare Gmbh
15.13.1 Company Snapshot
15.13.2 Revenue Analysis
15.13.3 Product Portfolio
15.13.4 Recent Development
16 Questionnaire
17 Related Reports
List Of Tables
Table 1 Europe Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 2 Europe Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 3 Europe Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 4 Europe Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 5 Europe Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 6 Europe Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 7 Europe Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 8 Europe Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 9 Europe Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 10 Europe Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 11 Europe Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 12 Europe Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 13 Europe Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 14 Europe Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million)
Table 15 Europe Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million)
Table 16 Europe Radiopharmaceuticals Market, By Country, 2021-2030 (Usd Million)
Table 17 Europe Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 18 Europe Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 19 Europe Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 20 Europe Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 21 Europe Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 22 Europe Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 23 Europe Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 24 Europe Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 25 Europe Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 26 Europe Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 27 Europe Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 28 Europe Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 29 Europe Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 30 Europe Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 31 Europe Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 32 Europe Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 33 Europe Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 34 Europe Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 35 Europe Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 36 Europe Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 37 Europe Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 38 Europe Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 39 Europe Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 40 Europe Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million)
Table 41 Europe Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million)
Table 42 Germany Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 43 Germany Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 44 Germany Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 45 Germany Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 46 Germany Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 47 Germany Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 48 Germany Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 49 Germany Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 50 Germany Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 51 Germany Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 52 Germany Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 53 Germany Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 54 Germany Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 55 Germany Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 56 Germany Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 57 Germany Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 58 Germany Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 59 Germany Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 60 Germany Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 61 Germany Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 62 Germany Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 63 Germany Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 64 Germany Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 65 Germany Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million)
Table 66 Germany Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million)
Table 67 U.K. Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 68 U.K. Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 69 U.K. Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 70 U.K. Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 71 U.K. Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 72 U.K. Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 73 U.K. Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 74 U.K. Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 75 U.K. Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 76 U.K. Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 77 U.K. Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 78 U.K. Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 79 U.K. Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 80 U.K. Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 81 U.K. Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 82 U.K. Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 83 U.K. Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 84 U.K. Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 85 U.K. Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 86 U.K. Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 87 U.K. Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 88 U.K. Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 89 U.K. Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 90 U.K. Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million)
Table 91 U.K. Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million)
Table 92 France Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 93 France Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 94 France Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 95 France Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 96 France Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 97 France Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 98 France Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 99 France Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 100 France Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 101 France Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 102 France Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 103 France Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 104 France Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 105 France Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 106 France Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 107 France Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 108 France Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 109 France Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 110 France Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 111 France Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 112 France Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 113 France Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 114 France Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 115 France Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million)
Table 116 France Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million)
Table 117 Italy Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 118 Italy Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 119 Italy Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 120 Italy Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 121 Italy Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 122 Italy Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 123 Italy Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 124 Italy Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 125 Italy Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 126 Italy Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 127 Italy Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 128 Italy Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 129 Italy Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 130 Italy Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 131 Italy Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 132 Italy Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 133 Italy Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 134 Italy Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 135 Italy Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 136 Italy Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 137 Italy Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 138 Italy Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 139 Italy Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 140 Italy Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million)
Table 141 Italy Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million)
Table 142 Spain Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 143 Spain Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 144 Spain Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 145 Spain Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 146 Spain Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 147 Spain Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 148 Spain Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 149 Spain Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
List Of Figures
Figure 1 Europe Radiopharmaceuticals: Segmentation
Figure 2 Europe Radiopharmaceuticals Market: Data Triangulation
Figure 3 Europe Radiopharmaceuticals Market: Droc Analysis
Figure 4 Europe Radiopharmaceuticals Market: Regional Market Analysis
Figure 5 Europe Radiopharmaceuticals Market: Company Research Analysis
Figure 6 Europe Radiopharmaceuticals Market: Interview Demographics
Figure 7 Europe Radiopharmaceuticals Market: Dbmr Market Position Grid
Figure 8 Europe Radiopharmaceuticals Market: Market Type Coverage Grid
Figure 9 Europe Radiopharmaceuticals Market: Segmentation
Figure 10 The Rising Prevalence Of Chronic Diseases Is Expected To Drive The Europe Radiopharmaceuticals Market In The Forecast Period
Figure 11 The Type Segment Is Expected To Account For The Largest Share Of The Europe Radiopharmaceuticals Market In 2023 & 2030
Figure 12 Drivers, Restraints, Opportunities, And Challenges Of The Europe Radiopharmaceuticals Market
Figure 13 Europe Radiopharmaceuticals Market: By Type, 2022
Figure 14 Europe Radiopharmaceuticals Market: By Type, 2023-2030 (Usd Million)
Figure 15 Europe Radiopharmaceuticals Market: By Type, Cagr (2023-2030)
Figure 16 Europe Radiopharmaceuticals Market: By Type, Lifeline Curve
Figure 17 Europe Radiopharmaceuticals Market: By Application, 2022
Figure 18 Europe Radiopharmaceuticals Market: By Application, 2023-2030 (Usd Million)
Figure 19 Europe Radiopharmaceuticals Market: By Application, Cagr (2023-2030)
Figure 20 Europe Radiopharmaceuticals Market: By Application, Lifeline Curve
Figure 21 Europe Radiopharmaceuticals Market: By Source, 2022
Figure 22 Europe Radiopharmaceuticals Market: By Source, 2023-2030 (Usd Million)
Figure 23 Europe Radiopharmaceuticals Market: By Source, Cagr (2023-2030)
Figure 24 Europe Radiopharmaceuticals Market: By Source, Lifeline Curve
Figure 25 Europe Radiopharmaceuticals Market: By End User, 2022
Figure 26 Europe Radiopharmaceuticals Market: By End User, 2023-2030 (Usd Million)
Figure 27 Europe Radiopharmaceuticals Market: By End User, Cagr (2023-2030)
Figure 28 Europe Radiopharmaceuticals Market: By End User, Lifeline Curve
Figure 29 Europe Radiopharmaceuticals Market: Snapshot (2022)
Figure 30 Europe Radiopharmaceuticals Market: By Country (2022)
Figure 31 Europe Radiopharmaceuticals Market: By Country (2023 & 2030)
Figure 32 Europe Radiopharmaceuticals Market: By Country (2022 & 2030)
Figure 33 Europe Radiopharmaceuticals Market: By Type (2023-2030)
Figure 34 Europe Radiopharmaceuticals Market: Company Share 2022 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings